Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy

Huizhuo Pan,Lianyue Li,Gaoju Pang,Chunli Han,Baona Liu,Yingying Zhang,Yue Shen,Tao Sun,Jing Liu,Jin Chang,Hanjie Wang

DOI: https://doi.org/10.1016/j.cej.2021.130842

IF: 15.1

2021-12-01

Chemical Engineering Journal

Abstract:<p>Engineered anaerobic bacteria known as live biotherapeutic products (LBPs) have shown great advances in cancer therapy. One advantage of anaerobic bacteria as drug carrier is that it spontaneously target to tumor and persistently release anti-tumor factors. To realize effective anti-cancer therapeutics, one essential premise is to improve the controllability of treatment. Here, we designed near-infrared (NIR)-light responsive bacteria as anti-tumor agent, which is based on a blue-light responsive module and upconversion nanoparticles. The upconversion nanoparticles converted external NIR light to local blue light to noninvasively activate blue-light responsive module (EL222) in engineered LBPs. The activated LBPs then produce tumor necrosis factor α (TNFα) for precise tumor ablation. <em>In vitro</em> and <em>in vivo</em> results have proven that this engineered NIR-light-responsive bacteria could efficiently inhibit tumor growth. We anticipate that this controllable and safe bacteria-based therapy can facilitate the application of LBPs to accurately and effectively regulate diseases.</p>

engineering, chemical, environmental

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to achieve more precise and controllable drug delivery in cancer treatment. Specifically, the researchers designed an engineered bacterium that responds to near - infrared light (NIR) as an anti - tumor agent for targeted and precise cancer treatment. This bacterium can spontaneously target tumors and achieve precise drug release in the tumor area through non - invasive activation by external near - infrared light. The main goal of the study is to improve the effectiveness and safety of tumor treatment while reducing side effects on normal tissues.

The key challenges mentioned in the paper include:
1. **Improving the controllability of treatment**: Although anaerobic bacteria can spontaneously target tumor sites, existing treatment methods lack effective control methods for drug production.
2. **Achieving a non - invasive light - control mechanism**: Using light as a control signal has the advantages of non - invasiveness and non - toxicity, but visible light has difficulty penetrating deep tissues. Therefore, the researchers use up - conversion nanomaterials to convert near - infrared light that penetrates deep tissues into local visible light to activate the photosensitive module in the bacteria.
3. **Ensuring biocompatibility and safety**: To ensure the safety of treatment, the researchers also designed an L - arabinose - dependent suicide system that can clear residual bacteria in the body after treatment and avoid potential risks.

Through these innovations, the researchers aim to develop a new, controllable, and safe cancer treatment method based on living - organism - based therapeutic products.